Sort
78,016 grants matching “breast cancer”
BREAST CANCER SURVIVORS: EXERCISE AND RALOXIFENE
$502,804Oregon Health And Science University · R01 · FY2002 · NR
Leveraging Sphingolipid Metabolism for Optimal Response of Breast Cancer Cells to Chemotherapy
$502,794Chiara Luberto · State University New York Stony Brook · P01 · FY2025 · CA
Development of injectable solvent-free tissue-mimetic platform for breast reconstructive surgery
$502,786Sergei Sheiko · Univ Of North Carolina Chapel Hill · R01 · FY2025 · EB
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$502,765David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Genomic, clinical and behavioral signature of long-term breast cancer survival
$502,763Loki Natarajan · University Of California, San Diego · R01 · FY2014 · CA
Acoustic Angiography Using Dual-Frequency and Ultrawideband CMUT Arrays
$502,763Omer Oralkan · North Carolina State University Raleigh · R01 · FY2018 · EB
MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer
$502,751Olga Anczukow-Camarda · Jackson Laboratory · R01 · FY2025 · CA
HippoPCI Hippocampal Predictors of Cognitive Impairment in Breast Cancer Patients
$502,743Lei Wang · Northwestern University At Chicago · R01 · FY2012 · NR
Genomics of Human Cancer
$502,725Cold Spring Harbor Laboratory · R01 · FY2004 · CA
Molecular and biochemical basis of Lymphangioleiomyomatosis
$502,724John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · HL
Molecular and biochemical basis of Lymphangioleiomyomatosis
$502,724John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · HL
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$502,655Periasamy Selvaraj · Emory University · R01 · FY2016 · CA
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
$502,653James K Turkson · University Of Hawaii At Manoa · R01 · FY2018 · CA
Australian Breast Cancer Family Registry
$502,630John L Hopper · University Of Melbourne · U01 · FY2006 · CA
Products of the Transforming Genes of Polyomavirus
$502,618Brian S Schaffhausen · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Patient Navigation 2.0: Addressing the Challenge of Scaling Navigation through Checklist-based Implementation
$502,590Melissa A. Simon · Northwestern University At Chicago · R01 · FY2024 · CA
Targeting non-homologous end joining in cancer therapy
$502,557Ralph Scully · Beth Israel Deaconess Medical Center · RC1 · FY2009 · CA
Targeted Inhibition in Leukemia
$502,537Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Developmental Funds
$502,500Eric P Winer · Yale University · P30 · FY2025 · CA
Statistical Genetics of Dose Response Traits
$502,429Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Breast Cancer, Radiation and the ATM-CHEK2 Pathway
$502,390Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$502,349Lawrence G Lum · Wayne State University · R01 · FY2011 · CA
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
$502,337Mark A. Lemmon · Yale University · R01 · FY2024 · CA
Therapeutic targeting of autophagy-dependent cancer
$502,312Andrew M Thorburn · University Of Colorado Denver · R01 · FY2015 · CA
Modeling Response to HER2 target therapies
$502,262Joe W. Gray · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2011 · CA